Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimonabant and metformin combinations for untreated type 2 diabetes
2008-002500-26Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of rimonabant and metformin in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Sanofi. Primary endpoint: Change in hemoglobin A1C from baseline at 9 months. Started Sep 2008; status: terminated.
02
Drugs
rimonabantmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-002500-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002500-26.